Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 89.35
Lilly Endowment, Inc. 10.51
The Vanguard Group, Inc. 7.54
Vanguard Group, Inc. (Subfiler) 7.17
PNC Financial Services Group, Inc. (13F Subfiler) 5.45
PNC Bank, NA (Investment Management) 5.43
State Street Corp. 3.56
Capital Research & Management Co. (World Investors) 2.84
Vanguard Total Stock Market ETF 2.83
Fidelity Management & Research Co. LLC 2.62
BlackRock Fund Advisors 2.38
PRIMECAP Management Co. 2.34
T Rowe Price Associates, Inc. (13F Subfiler) 2.18
Vanguard 500 Index Fund 2.08
BlackRock Institutional Trust Co. NA 1.92

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 33'625 35'000 35'000 39'000 43'000
Umsatz pro Mitarbeiter in Mio. EUR 0.66 0.70 0.81 0.73 0.79

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 13'710 17'462 18'452 18'035 25'727
Summe Anlagevermögen 18'533 22'237 25'864 26'888 35'997
Summe Aktiva 39'286 46'633 48'806 49'490 64'006

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 15'926 16'595 16'885 16'239 25'225
Summe Fremdkapital 36'587 40'808 39'651 38'714 53'143
Summe Eigenkapital 2'699 5'825 9'155 10'775 10'864
Summe Passiva 39'286 46'633 48'806 49'490 64'006

Adresse

Lilly Corporate Center, 46285 Indianapolis
Telefon +1 (317) 276-2000
URL http://www.lilly.com

Management

Alonzo Weems
Executive VP, Chief Ethics & Compliance Officer
Anat Ashkenazi
Chief Financial Officer & Executive Vice President
Anat Hakim
Secretary, Executive VP & General Counsel
Andy Vicari
Senior Director & US Brand Leader-Insulins
Anne E. White
Executive Vice President
Christian Nguyen
VP-Global Patient Outcomes & Real World Evidence
Daniel M. Skovronsky
Chief Scientific Officer & Executive VP
David A. Ricks
Chairman, President & Chief Executive Officer
David Hyman
Chief Medical Officer
Diogo Rau
Executive VP, Chief Information & Digital Officer
Donald A. Zakrowski
Chief Accounting Officer & Vice President-Finance
Edgardo Hernandez
President-Manufacturing Operations & Senior VP
Eric Dozier
Executive VP-Human Resources & Diversity
Gabrielle G. Greene-Sulzberger
Independent Director
Ilya Yuffa
Senior VP & President-Lilly Bio-Medicines
Jamere Jackson
Independent Director
Jennifer Oleksiw
Global Chief Customer Officer & Vice President
Joe Fletcher
Investor Relations Contact
Johna L. Norton
Executive Vice President-Global Quality
Jon Erik Fyrwald
Independent Director
Juan Ricardo Luciano
Lead Independent Director
Karen Walker
Independent Director
Katherine Baicker
Independent Director
Kim Macko
Head-Global Brand Development
Kimberly H. Johnson
Independent Director
Laura A. Lane
Vice President
Mark Genovese
Senior Vice President-Immunology Development
Marschall S. Runge
Independent Director
Mary Lynne Hedley
Independent Director
Nathaniel R. Miles
Vice President-Strategic Initiatives
Patrik Jonsson
Chief Customer Officer, EVP & President-Lilly USA
Philip L. Johnson
Treasurer & Vice President
Ralph Alvarez
Independent Director
Robert Conley
Development Leader-Neuroscience
Robert J. Heine
Vice President-Medical Affairs
Ronald DeMattos
Senior Vice President
Ruth Gimeno
Vice President
Travis Coy
VP, Head-Transactions & Business Development
William G. Kaelin
Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen